Since you ‘cannot change what you cannot measure’, Brad endeavors to bring accessible, affordable, and scientifically sound aging biomarkers to the general public. As a researcher, Brad investigates these age-associated changes — epigenetic methylation marks — looking for why they accompany such profound, unprecedented consequences, in both naturally aged tissue and reprogrammed cells.
